Cadonilimab plus gemcitabine and cisplatin as first-line treatment for unresectable locally advanced or…

Efficacy and toxicities of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for unresectable pancreatic cancer: a systematic review and meta-analysis
Chunle Hu, Li Zhan, Yanhui Li +2
Frontiers in oncology16 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMC
Combined Hepatocellular-cholangiocarcinoma Patient Treated with Durvalumab Plus Gemcitabine and Cisplatin
Daisuke Kobayashi, Manabu Hayashi, Yosuke Takahata +12
Internal Medicine15 Oct 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
Pembrolizumab plus gemcitabine and cisplatin for advanced biliary tract cancer: longer-term follow-up from the randomised, double-blind, placebo-controlled, phase 3 KEYNOTE-966 trial
Makoto Ueno, Changhoon Yoo, Zhenggang Ren +206
eClinicalMedicine1 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Surgery & anaesthesiaCrossref
Comparative Evaluation of Concurrent Carboplatin-Paclitaxel Versus Cisplatin-Etoposide Chemoradiotherapy in Unresectable Non-small Cell Lung Cancer: A Prospective Randomized Study
Yamini Kumar, Bala Venkat Subramanian, G V Deepthi +2
Cureus16 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Initial Clinical Experience With Gemcitabine, Cisplatin, and Nivolumab for Advanced Urothelial Carcinoma: A Four-case Series
SHUJI TSUBOTA, GO KANEKO, DAISUKE IGARASHI +3
In Vivo29 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaPMC

Cite

BibTeX

@article{ma2026cadonilimab,
  title = {{Cadonilimab plus gemcitabine and cisplatin as first-line treatment for unresectable locally advanced or metastatic biliary tract malignancies: the phase II bicureX clinical trial}},
  author = {Ji Ma and Tao Wang and Yichen Zheng and Tonghui Ren and Dongdong Zhu and Yiwen Qiu and Yi Yang and Li Jiang and Shu Shen and Wentao Wang},
  journal = {Nature Communications},
  year = {2026},
  month = oct,
  doi = {10.1038/s41467-026-78413-z},
  url = {https://www.nature.com/articles/s41467-026-78413-z},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - Cadonilimab plus gemcitabine and cisplatin as first-line treatment for unresectable locally advanced or metastatic biliary tract malignancies: the phase II bicureX clinical trial
AU  - Ji Ma
AU  - Tao Wang
AU  - Yichen Zheng
AU  - Tonghui Ren
AU  - Dongdong Zhu
AU  - Yiwen Qiu
AU  - Yi Yang
AU  - Li Jiang
AU  - Shu Shen
AU  - Wentao Wang
PY  - 2026
DA  - 2026/10/19
JO  - Nature Communications
DO  - 10.1038/s41467-026-78413-z
UR  - https://www.nature.com/articles/s41467-026-78413-z
SN  - 2041-1723
ER  -

Related

Cite